Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy.

Autor:in

Imre, Gergely; Takács, Bertalan; Czipa, Erik; Drubi, Andrea Bakné; Jaksa, Gábor; Latinovics, Dóra; Nagy, Andrea; Karkas, Réka; Hudoba, Liza; Vásárhelyi, Bálint Márk; Pankotai-Bodó, Gabriella; Blastyák, András; Hegedűs, Zoltán; Germán, Péter; Bálint, Balázs; Ahmed Abdullah, Khaldoon Sadiq; Kopasz, Anna Georgina; Kovács, Anita; Nagy, László G; Sükösd, Farkas; Pintér, Lajos; Rülicke, Thomas; Barta, Endre; Nagy, István; Haracska, Lajos; Mátés, Lajos

Schlagwörter

TYROSINEMIA TYPE-I; SLEEPING-BEAUTY TRANSPOSASE; PIGGYBAC TRANSPOSON; MURINE MODEL; HEPATIC-DYSFUNCTION; SITE SELECTION; MOUSE-LIVER; METHYLATIONS; MUTAGENESIS; EXPRESSION

CC Lizenz

CCBY

ISSN/eISSN

2329-0501 - 2329-0501

WoS ID

WOS:001043227200001

Repository Phaidra

o:2217